1Reichenbach JR,Venkatesan R,Schillinger DJ,et al.Smallvessels in the human brain:MR venography with deoxyhe-moglobin as an intrinsic contrast agent. Radiology . 1997
2Hu LS,Baxter LC,Smith KA,et al.Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect:Direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements[J].Am J Neuroradiol,2009,30(3):552-558.
3Park MJ,Kim HS,Jahng GH,et al.Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas:Comparison with MR perfusion imaging[J].Am J Neuroradiol,2009,30(7):1402-1408.
4Hakyemez B,Erdogan C,Ercan I,et al.High-grade and low-grade gliomas:Differentiation by using perfusion MR imaging[J].Clin Radiol,2005,60(4):493-502.
5Liao W,Liu Y,Wang X,et al.Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging[J].Acta Radiol,2009,50(2):217-225.
6Vajkoczy P,Menger MD.Vascular microenvironment in gliomas[J].J Neurooncol,2000,50(1-2):99-108.
7Hilario A,Ramos A,Perez-Nunez A,et al.The Added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas[J].AJNR Am J Neuroradiol,2011,29:1-7.
8Weber MA,Zoubaa S,Schlieter M,et al.Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors[J].Neurology,2006,66(12):1899-1906.
